KAPLAN-MEIER ESTIMATE EXAMPLE DATA

← Back to document page

1. ALL (acute lymphoblastic leukemia) 2. AML (acute myelocytic leukemia) – Low Risk 3. AML (acute myelocytic leukemia) – High Risk The endpoint is disease-free survival time: time (in days) until death, relapse, or end of study. The SAS variables are • T = disease-free survival time • Status = event indicator: 1= event, 0= censored

  Acute, Leukemia, Lymphoblastic, Acute lymphoblastic leukemia